ArticleCancer medicine2023

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non-small cell lung cancer.

Lei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.